|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Cabaletta Bio, Inc. (CABA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
51,420,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Co.'s proprietary technology utilizes Chimeric AutoAntibody Receptor, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Co.'s main CAAR T cell product candidate was designed based on the Chimeric Antigen Receptor, T cell technology that is marketed for the treatment of B cell cancers. Co.'s initial focus is mucosal pemphigus vulgaris, which is an autoimmune blistering disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
346,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$343,789 |
Total People Bought |
0 |
0 |
0 |
5 |
Total Buy Transactions |
0 |
0 |
0 |
7 |
Total Shares Sold |
0 |
22,000 |
88,000 |
110,000 |
Total Sell Value |
$0 |
$456,228 |
$1,434,913 |
$1,694,746 |
Total People Sold |
0 |
1 |
1 |
1 |
Total Sell Transactions |
0 |
2 |
8 |
9 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Binder Gwendolyn |
See Remarks |
|
2024-01-19 |
4 |
AS |
$19.54 |
$215,439 |
D/D |
(11,000) |
20,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2024-01-19 |
4 |
OE |
$1.01 |
$11,110 |
D/D |
11,000 |
31,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-12-19 |
4 |
AS |
$21.76 |
$240,789 |
D/D |
(11,000) |
20,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-12-19 |
4 |
OE |
$1.01 |
$11,110 |
D/D |
11,000 |
31,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-11-20 |
4 |
AS |
$17.39 |
$196,014 |
D/D |
(11,000) |
20,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-11-20 |
4 |
OE |
$1.01 |
$11,110 |
D/D |
11,000 |
31,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-10-19 |
4 |
AS |
$13.32 |
$146,921 |
D/D |
(11,000) |
20,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-10-19 |
4 |
OE |
$1.01 |
$11,110 |
D/D |
11,000 |
31,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-09-19 |
4 |
AS |
$17.50 |
$193,220 |
D/D |
(11,000) |
20,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-09-19 |
4 |
OE |
$1.01 |
$11,110 |
D/D |
11,000 |
31,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-08-21 |
4 |
AS |
$13.41 |
$147,583 |
D/D |
(11,000) |
20,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-08-21 |
4 |
OE |
$1.01 |
$11,110 |
D/D |
11,000 |
31,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-07-19 |
4 |
AS |
$13.67 |
$152,022 |
D/D |
(11,000) |
20,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-07-19 |
4 |
OE |
$1.01 |
$11,110 |
D/D |
11,000 |
31,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-06-20 |
4 |
AS |
$12.99 |
$142,925 |
D/D |
(11,000) |
20,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-06-20 |
4 |
OE |
$1.01 |
$11,110 |
D/D |
11,000 |
31,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-05-19 |
4 |
AS |
$11.81 |
$259,833 |
D/D |
(22,000) |
20,000 |
|
- |
|
Binder Gwendolyn |
See Remarks |
|
2023-05-19 |
4 |
OE |
$1.01 |
$22,220 |
D/D |
22,000 |
42,000 |
|
- |
|
Nichtberger Steven |
President & CEO |
|
2022-10-19 |
4 |
B |
$1.25 |
$10,152 |
D/D |
8,127 |
986,483 |
2.81 |
- |
|
Nichtberger Steven |
President & CEO |
|
2022-10-18 |
4 |
B |
$0.99 |
$141,008 |
D/D |
141,873 |
978,356 |
2.81 |
- |
|
Simon Mark |
Director |
|
2022-10-18 |
4 |
B |
$0.98 |
$6,835 |
I/I |
7,000 |
7,000 |
2.1 |
- |
|
Simon Mark |
Director |
|
2022-10-18 |
4 |
B |
$0.98 |
$115,286 |
D/D |
118,000 |
136,144 |
2.39 |
- |
|
Marda Anup |
Chief Financial Officer |
|
2022-10-18 |
4 |
B |
$0.99 |
$49,620 |
D/D |
50,000 |
50,000 |
2.74 |
- |
|
Binder Gwendolyn |
See Remarks |
|
2022-10-18 |
4 |
B |
$0.99 |
$19,894 |
D/D |
20,000 |
20,000 |
2.74 |
- |
|
Bollard Catherine |
Director |
|
2022-10-18 |
4 |
B |
$0.99 |
$994 |
D/D |
1,000 |
1,000 |
2.31 |
- |
|
40 Records found
|
|
Page 1 of 2 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|